We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$775M
AUM Growth
-$436M
Cap. Flow
-$471M
Cap. Flow %
-60.72%
Top 10 Hldgs %
18.21%
Holding
4,545
New
711
Increased
1,179
Reduced
1,568
Closed
1,030

Sector Composition

Rank Sector Weight
1 Financials 11.08%
2 Technology 10%
3 Consumer Discretionary 7.02%
4 Healthcare 6.86%
5 Communication Services 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAGN
4101
Magnera Corp
MAGN
$472M
-507
Closed -$129K
ENFY
4102
DELISTED
Enlightify Inc
ENFY
$0 ﹤0.01%
+17
New +$257
ABLG
4103
Abacus FCF International Leaders ETF
ABLG
$16M
-200
Closed -$5K
PVLA
4104
Palvella Therapeutics
PVLA
$1.99B
-52
Closed -$24K
JXG
4105
JX Luxventure
JXG
0
AAMI
4106
Acadian Asset Management
AAMI
$3.08B
-3,715
Closed -$55K
XYZ
4107
Block Inc
XYZ
$48.4B
-1
Closed
BLNE
4108
Beeline Holdings
BLNE
$28.8M
-1
Closed
QVCGB
4109
DELISTED
QVC Group, Inc. Series B Common Stock
QVCGB
0
NAGE
4110
Niagen Bioscience
NAGE
$271M
-1,159
Closed -$5K
BCPC
4111
Balchem Corp
BCPC
$5.38B
-3,942
Closed -$321K
LGF.B
4112
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
-1,600
Closed -$51K
BECN
4113
DELISTED
Beacon Roofing Supply, Inc.
BECN
-12,277
Closed -$629K
ITCI
4114
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-4,091
Closed -$65K
SASR
4115
DELISTED
Sandy Spring Bancorp Inc
SASR
-2,392
Closed -$99K
ATXI
4116
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
-7
Closed -$41K
ROIC
4117
DELISTED
Retail Opportunity Investments Corp.
ROIC
-9,011
Closed -$171K
SUM
4118
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
-12,446
Closed -$375K
SCWX
4119
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
-3,493
Closed -$43K
VIRX
4120
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
-241
Closed -$16K
B
4121
DELISTED
Barnes Group Inc.
B
-5,944
Closed -$419K
USAP
4122
DELISTED
Universal Stainless & Alloy
USAP
-615
Closed -$12.9K
CNSL
4123
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
-3,506
Closed -$67K
WHLM
4124
DELISTED
Wilhelmina International, Inc
WHLM
-506
Closed -$3K
AKTS
4125
DELISTED
Akoustis Technologies Inc
AKTS
-2,010
Closed -$13K

Similar funds

Tower Research Capital (TRC)'s Q4 2017 Portfolio in Review

As of Q4 2017, Tower Research Capital (TRC) held 4,545 positions worth $775M, down 36% from $1.21B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Tower Research Capital (TRC) withdrew a net $471M in Q4 2017, closing 1,030 positions and reducing 1,568 holdings. Its most notable exit was iShares MSCI EAFE ETF, an estimated $25.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 6.3% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Berkshire Hathaway Class B worth $7.94M.

  • Tower Research Capital (TRC)'s largest Q4 2017 buy was Berkshire Hathaway Class B: 40,072 shares worth $7.94M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2017, an estimated $8.74M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $223M.
  • Tower Research Capital (TRC) fully exited iShares MSCI EAFE ETF in Q4 2017, selling an estimated $25.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 18% of its $775M portfolio in Q4 2017.
  • Tower Research Capital (TRC) opened 711 new positions and closed 1,030 in Q4 2017.
  • Tower Research Capital (TRC)'s portfolio value fell 36% quarter-over-quarter to $775M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2017, filed 9 Feb 2018.